Eva Altrock

464 total citations
15 papers, 314 citations indexed

About

Eva Altrock is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Eva Altrock has authored 15 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Hepatology and 3 papers in Epidemiology. Recurrent topics in Eva Altrock's work include Liver physiology and pathology (4 papers), Cell Adhesion Molecules Research (3 papers) and Acute Myeloid Leukemia Research (2 papers). Eva Altrock is often cited by papers focused on Liver physiology and pathology (4 papers), Cell Adhesion Molecules Research (3 papers) and Acute Myeloid Leukemia Research (2 papers). Eva Altrock collaborates with scholars based in Germany, United States and Netherlands. Eva Altrock's co-authors include Inaam A. Nakchbandi, Carla Sens, Cornelia Lee‐Thedieck, Joachim P. Spatz, Gerd Klein, Steven Dooley, N. Kawelke, Jane Sottile, Ilia Platzman and Yvonne Samstag and has published in prestigious journals such as Nature Communications, Biomaterials and Cancer Research.

In The Last Decade

Eva Altrock

14 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Altrock Germany 8 101 73 71 67 66 15 314
Steven King United States 3 288 2.9× 116 1.6× 87 1.2× 54 0.8× 19 0.3× 8 469
Tomomi Hirosaki Japan 10 144 1.4× 53 0.7× 264 3.7× 81 1.2× 155 2.3× 11 455
Franziska Leonhardt Germany 10 145 1.4× 58 0.8× 27 0.4× 105 1.6× 18 0.3× 13 385
Angela R. Blissett United States 8 126 1.2× 77 1.1× 76 1.1× 14 0.2× 50 0.8× 11 396
Stefanie Nittka Germany 11 106 1.0× 93 1.3× 21 0.3× 20 0.3× 9 0.1× 16 388
Angelica Trujillo United States 8 237 2.3× 72 1.0× 75 1.1× 46 0.7× 58 0.9× 10 399
Michael L. Basara United States 6 116 1.1× 81 1.1× 169 2.4× 19 0.3× 107 1.6× 11 406
Masato Naito Japan 5 176 1.7× 40 0.5× 21 0.3× 17 0.3× 22 0.3× 14 366
Suvi Natunen Finland 12 308 3.0× 54 0.7× 25 0.4× 84 1.3× 48 0.7× 14 509
Vincenzo Ingangi Italy 12 142 1.4× 120 1.6× 33 0.5× 16 0.2× 19 0.3× 15 323

Countries citing papers authored by Eva Altrock

Since Specialization
Citations

This map shows the geographic impact of Eva Altrock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Altrock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Altrock more than expected).

Fields of papers citing papers by Eva Altrock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Altrock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Altrock. The network helps show where Eva Altrock may publish in the future.

Co-authorship network of co-authors of Eva Altrock

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Altrock. A scholar is included among the top collaborators of Eva Altrock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Altrock. Eva Altrock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Xu, Qingyu, Ling Ma, Eva Altrock, et al.. (2025). Machine learning-based in-silico analysis identifies signatures of lysyl oxidases for prognostic and therapeutic response prediction in cancer. Cell Communication and Signaling. 23(1). 169–169.
2.
Xu, Qingyu, Eva Altrock, Verena Nowak, et al.. (2023). In Silico Pan-Cancer Analysis Reveals Prognostic Role of the Erythroferrone (ERFE) Gene in Human Malignancies. International Journal of Molecular Sciences. 24(2). 1725–1725. 1 indexed citations
3.
Keller, Anita C., et al.. (2022). Do influence at work and possibilities for development mitigate the impact of job demands for workers with and without depression. Scandinavian Journal of Work Environment & Health. 49(2). 136–144. 2 indexed citations
4.
Jann, Johann-Christoph, Maximilian Mossner, Vladimir Riabov, et al.. (2021). Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo. Nature Communications. 12(1). 6170–6170. 12 indexed citations
5.
Flach, Johanna, Johann-Christoph Jann, Vladimir Riabov, et al.. (2020). Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations. Haematologica. 106(11). 2906–2917. 24 indexed citations
6.
Groth, Christopher, Eva Altrock, Franz Jakob, et al.. (2017). A Subpopulation of Stromal Cells Controls Cancer Cell Homing to the Bone Marrow. Cancer Research. 78(1). 129–142. 30 indexed citations
7.
Altrock, Eva, Carla Sens, Michael D. Milsom, et al.. (2016). EDA-Fibronectin Originating from Osteoblasts Inhibits the Immune Response against Cancer. PLoS Biology. 14(9). e1002562–e1002562. 29 indexed citations
8.
Sens, Carla, Eva Altrock, Verena Klemis, et al.. (2016). An O-Glycosylation of Fibronectin Mediates Hepatic Osteodystrophy Through α4β1 Integrin. Journal of Bone and Mineral Research. 32(1). 70–81. 20 indexed citations
9.
Altrock, Eva, et al.. (2015). Loss of Integrin-β1 in Hepatocytes Induces Liver Fibrosis. Zeitschrift für Gastroenterologie. 53(1). 1 indexed citations
10.
Altrock, Eva, et al.. (2015). Inflammatory cell infiltration in experimental liver fibrosis is affected by inhibition of fibronectin matrix assembly. Zeitschrift für Gastroenterologie. 53(1). 2 indexed citations
11.
Altrock, Eva, Carla Sens, N. Kawelke, et al.. (2014). Inhibition of fibronectin deposition improves experimental liver fibrosis. Journal of Hepatology. 62(3). 625–633. 96 indexed citations
12.
Altrock, Eva, et al.. (2014). P619 INHIBITION OF FIBRONECTIN DEPOSITION IMPROVES EXPERIMENTAL LIVER FIBROSIS. Journal of Hepatology. 60(1). S275–S275. 2 indexed citations
13.
Shipkova, Maria, et al.. (2013). CD26/dipeptidyl peptidase IV: A comparative study of healthy persons and kidney transplant recipients before and early after transplantation. Clinical Biochemistry. 46(15). 1383–1388. 7 indexed citations
14.
Platzman, Ilia, Cornelia Lee‐Thedieck, Diego Pallarola, et al.. (2013). Surface properties of nanostructured bio-active interfaces: impacts of surface stiffness and topography on cell–surface interactions. RSC Advances. 3(32). 13293–13293. 25 indexed citations
15.
Altrock, Eva, et al.. (2012). The significance of integrin ligand nanopatterning on lipid raft clustering in hematopoietic stem cells. Biomaterials. 33(11). 3107–3118. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026